000			01450 a2200397 4500
005			20250515023043.0
264		0	_c20060802
008			200608s 0 0 eng d
022			_a0924-8579
024	7		_a10.1016/j.ijantimicag.2006.02.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aSteward, J
245	0	0	_aTreatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin. _h[electronic resource]
260			_bInternational journal of antimicrobial agents _cMay 2006
300			_a439-43 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aAza Compounds _xtherapeutic use
650	0	4	_aCiprofloxacin _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFluoroquinolones _xtherapeutic use
650	0	4	_aGatifloxacin
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMoxifloxacin
650	0	4	_aPneumonia, Bacterial _xdrug therapy
650	0	4	_aQuinolines _xtherapeutic use
650	0	4	_aTularemia _xdrug therapy
700	1		_aPiercy, T
700	1		_aLever, M S
700	1		_aSimpson, A J H
700	1		_aBrooks, T J G
773	0		_tInternational journal of antimicrobial agents _gvol. 27 _gno. 5 _gp. 439-43
856	4	0	_uhttps://doi.org/10.1016/j.ijantimicag.2006.02.006 _zAvailable from publisher's website
999			_c16226038 _d16226038